Analyst Maintains Sell Rating on Moderna Amid Revenue Guidance Downgrade and Competitive Challenges
Deutsche Bank Upgrades Moderna to Hold From Sell, Adjusts Price Target to $80 From $85
Moderna Analyst Ratings
Moderna Analyst Ratings
Moderna Stock Tumbles as RBC Cuts to Sector Perform on 'Uncertain Outlook'
RBC Capital Downgrades Moderna(MRNA.US) to Hold Rating, Cuts Target Price to $90
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
Goldman Sachs Adjusts Price Target on Moderna to $178 From $204
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $105 to $157
Moderna Faces Competitive Pressures and Lowered Revenue Projections: A Hold Rating
Moderna Analyst Ratings
RBC Adjusts Moderna's Price Target to $125 From $160
Redburn Raises Moderna's Price Target to $117 From $116
Moderna Analyst Ratings
Argus Raises Moderna's Price Target to $150 From $115
Moderna Analyst Ratings
Oppenheimer Raises Price Target on Moderna to $179 From $163
Jefferies Adjusts Price Target on Moderna to $180 From $155, Keeps Buy Rating
Moderna Analyst Ratings
Moderna Analyst Ratings